TherapeuticsMD (TXMD) Free Cash Flow (2010 - 2026)
TherapeuticsMD (TXMD) reported Free Cash Flow of $944000.0 for Q1 2026, up 35.05% on a YoY basis from $699000.0 in Q1 2025, and up 151.73% quarter-over-quarter from $375000.0 in Q4 2025.
TherapeuticsMD (TXMD) Free Cash Flow (2010 - 2026) Analysis & Trends
TherapeuticsMD has reported Free Cash Flow for 17 years, with the latest figure at $944000.0 in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 35.05% year-over-year to $944000.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 28.65% YoY), and the FY2025 full-year result was $2.5 million, up 109.74% from the prior year.
- Free Cash Flow for Q1 2026 stood at $944000.0, up from $375000.0 in the prior quarter.
- The five-year high for Free Cash Flow was $30.2 million in Q4 2022, with the low at -$20.7 million in Q2 2022.
- Historically, Free Cash Flow has averaged -$539705.9 across 5 years, with a median of $17000.0 in 2024.
- Annual changes were most pronounced in 2023 — Free Cash Flow tumbled 134.03% — and 2025, when it surged 2105.88%.
- TherapeuticsMD's Free Cash Flow stood at $30.2 million in 2022, then slumped by 116.4% to -$5.0 million in 2023, then jumped by 100.34% to $17000.0 in 2024, then surged by 2105.88% to $375000.0 in 2025, then jumped by 151.73% to $944000.0 in 2026.
- The last three Free Cash Flow figures came in at $944000.0 (Q1 2026), $375000.0 (Q4 2025), and $999000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | TherapeuticsMD | 21,180.42 | -8.40 Mn | - | 944,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944,000.00 |
| Mar 31, 2026 | 944,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | -229,000.00 |
| Mar 31, 2024 | -229,000.00 |
| Dec 31, 2023 | -4.96 Mn |
| Dec 31, 2023 | -4.96 Mn |